Donnell D, Baeten JM, Kiarie J, et al.. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort study

Statistical Center for HIV/AIDS Research and Prevention and the Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
The Lancet (Impact Factor: 45.22). 06/2010; 375(9731):2092-8. DOI: 10.1016/S0140-6736(10)60705-2
Source: PubMed


High plasma HIV-1 RNA concentrations are associated with increased risk of HIV-1 transmission. Initiation of antiretroviral therapy (ART) reduces plasma HIV-1 concentrations. We aimed to assess the effect of ART use by patients infected with HIV-1 on risk of transmission to their uninfected partners.
Participants in our prospective cohort analysis were from a randomised placebo-controlled trial that enrolled heterosexual African adults who were seropositive for both HIV-1 and herpes simplex virus type 2, and their HIV-1 seronegative partners. At enrolment, HIV-1 infected participants had CD4 counts of 250 cells per microL or greater and did not meet national guidelines for ART initiation; during 24 months of follow-up, CD4 counts were measured every 6 months and ART was initiated in accordance with national guidelines. Uninfected partners were tested for HIV-1 every 3 months. The primary outcome was genetically-linked HIV-1 transmission within the study partnership. We assessed rates of HIV-1 transmission by ART status of infected participants.
3381 couples were eligible for analysis. 349 (10%) participants with HIV-1 initiated ART during the study, at a median CD4 cell count of 198 (IQR 161-265) cells per microL. Only one of 103 genetically-linked HIV-1 transmissions was from an infected participant who had started ART, corresponding to transmission rates of 0.37 (95% CI 0.09-2.04) per 100 person-years in those who had initiated treatment and 2.24 (1.84-2.72) per 100 person-years in those who had not-a 92% reduction (adjusted incidence rate ratio 0.08, 95% CI 0.00-0.57, p=0.004). In participants not on ART, the highest HIV-1 transmission rate (8.79 per 100 person-years) was from those with CD4 cell counts lower than 200 cells per microL. In couples in whom the untreated HIV-1 infected partner had a CD4 cell count greater than 200 cells per microL, 66 (70%) of 94 transmissions occurred when plasma HIV-1 concentrations exceeded 50 000 copies per mL.
Low CD4 cell counts and high plasma HIV-1 concentrations might guide use of ART to achieve an HIV-1 prevention benefit. Provision of ART to HIV-1 infected patients could be an effective strategy to achieve population-level reductions in HIV-1 transmission.
Bill & Melinda Gates Foundation; US National Institutes of Health.

Download full-text


Available from: Wendy Susan Stevens
  • Source
    • "The transmission of HIV from mother-to-child during pregnancy, labour, delivery or breastfeeding can be as high as 45% in the absence of interventions, but with early diagnosis, prompt initiation of care and adherence to PMTCT services, the rate can be reduced to less than 5%[39,40]. Early diagnosis and prompt enrolment into care also helps to preserve the health of the pregnant woman while reducing the chances of HIV transmission to a male partner who is not infected[41,42]. Since it is known that provider-initiated modes of testing make testing accessible to women from lower socioeconomic groups, ANC services should promote HIV counselling and testing as an essential component of ANC service for all pregnant women. "

    Full-text · Article · Jan 2016 · Journal of the International AIDS Society
  • Source
    • "However, on the other hand, timely HIV testing provides the benefits of reduction of the spread of the virus and continued health of infected individuals through access to HIV health care services. Several studies have shown that patients who initiate early ART are less likely to spread the virus [6] [7] [8] . "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To assess the prevalence of HIV infection, to highlight HIV-testing refusal rates among participants in a population-based tuberculosis survey and to assess the implication for programme implementation. Methods: This cross-sectional study on the characteristics of participants who refused HIV testing was conducted in a national survey in Zambia. All eligible participants were aged above 15 years and included in the analysis. Results: Out of the 44 791 tuberculosis survey participants, 14 164 (31.6%) refused to participate in HIV testing. The unemployed, rural dwellers, married, and those aged 15- 24 years were associated with higher refusal rates. Conclusions: Strategies to improve HIV testing acceptance are necessary. Qualitative research is recommended to understand the reasons for testing refusals so that remedial interventions can be implemented.
    Full-text · Article · Jul 2015 · Asian Pacific Journal of Tropical Biomedicine
  • Source
    • "It is thus critical to examine the relationship between HIV transmission and treatment from multidimensional perspectives. Observational or experimental studies [10] [15] and a meta-analysis [9] demonstrated that the effectiveness of ART "
    [Show abstract] [Hide abstract]
    ABSTRACT: The preventative effects of antiretroviral therapy for people with HIV have been debated since they were first raised. Models commenced studying the preventive effects of treatment in the 1990s, prior to initial public reports. However, the outcomes of the preventive effects of antiretroviral use were not consistent. Some outcomes of dynamic models were based on unfeasible assumptions, such as no consideration of drug resistance, behavior disinhibition, or economic inputs in poor countries, and unrealistic input variables, for example, overstated initiation time, adherence, coverage, and efficacy of treatment. This paper reviewed dynamic mathematical models to ascertain the complex effects of ART on HIV transmission. This review discusses more conservative inputs and outcomes relative to antiretroviral use in HIV infections in dynamic mathematical models. ART alone cannot eliminate HIV transmission.
    Full-text · Article · Dec 2014
Show more